Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,646 public trials 848 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Not Yet Recruiting

High-Dose vs Standard Ergocalciferol for Vitamin D Normalization in Aggressive Non-Hodgkin Lymphoma

NCT07366450

Conditions: Avitaminosis, Deficiency Diseases, Hemic and Lymphatic Diseases, +15 more
Locations: Phramonkutklao Hospital Bangkok, Thailand

View Trial Details

Not Yet Recruiting

Clinical Study of Universal CD19 CAR-γδT Cell Injection in the Treatment of Adult Relapsed/Refractory B-cell Lymphoma

NCT07367685

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: The Second Affiliated Hospital of Fujian Medical University Quanzhou, Fujian, China

View Trial Details

Not Yet Recruiting

Optimizing Preeclampsia Postpartum With Point-of-care Ultrasound

NCT07167862

Conditions: Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, Hypertension, Pregnancy-Induced, +15 more
Locations: University of California Irvine Medical Center Orange, California, United States

View Trial Details

Not Yet Recruiting

Myopia Progression Control Using Atropine 0.05% After Pediatric Cataract Surgery And Intraocular Lens Implantation Surgery

NCT07364370

Conditions: Eye Diseases, Eye Neoplasms, Hemic and Lymphatic Diseases, +14 more
Locations: Cairo University Cairo, Egypt

View Trial Details

Not Yet Recruiting

Efficacy and Safety of TC011 in Relapsed or Refractory Follicular Lymphoma

NCT07360288

Conditions: Follicular Lymphoma (FL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Clinical Study on the Safety and Efficacy of CD20/CD19 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

NCT07345741

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, China

View Trial Details

Not Yet Recruiting

EZH2 Inhibitor Zeprumetostat in Combination Therapy for Patients With Relapsed or Refractory Mature T-cell and NK-cell Lymphomas

NCT07339527

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Effect of Inhaled Nitric Oxide Therapy in Adults With Moderate-to-Severe Acute Respiratory Distress Syndrome

NCT07334873

Conditions: ARDS (Moderate or Severe), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Clinical Study of XP-006 mRNA Vaccine for R/R B-NHL

NCT07334574

Conditions: B-cell Non-Hodgkin's Lymphoma (B-NHL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Ruijin Hospital Shanghai, China

View Trial Details

Not Yet Recruiting

A Clinical Study of of RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas

NCT07316920

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Affiliated Hospital of Jiangsu University Zhenjiang, Jiangsu, China

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions